About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Barriers to Physical Activity in People With MS | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04746807

Barriers to Physical Activity in People With MS

Multiple Sclerosis (MS) is a chronic inflammatory disease leading to the demyelination of the central nervous system. Promoting physical activity has gathered attention as an effective means to improv...

Lead sponsor: University of Zurich•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Zurich

Collaborators

Dr. Roman Gonzenbach, Kliniken Valens

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•aged 18 years or older
•definite diagnosis of relapsing or progressive MS (i.e., confirmed by their physician)
•persons with reduced walking ability but who are still able to walk independently with or without an assistive device (e.g., as expressed by an Expanded Disability Status Scale score between 3-6.5)
•possess a personal computer, mobile phone or a tablet with Bluetooth functionality,
•be willing and able to perform study procedures,
•be able to provide informed consent
•be able to answer the questionnaires in German.

Exclusion Criteria

•serious illnesses that preclude safe participation in physical activity
•inability to follow study procedures
•inability to complete questionnaires in German
•inability to complete baseline questionnaires or activate the Fitbit device will lead to the exclusion of the participant from the study

Related studies

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

RECRUITINGPhase 2

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490 · Multiple Sclerosis Spasticity

RECRUITINGPhase 3

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019 · Secondary Progressive Multiple Sclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 19, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment45

Start dateJan 2021

Last updatedNov 19, 2021

Condition

Multiple Sclerosis

Locations shown

Kliniken Valens

Valens

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions